Press releases

Month Year

Email alerts

Nov 6, 2021

Medtronic announces early data for the Intrepid™ transcatheter mitral valve replacement (TMVR) system using new transfemoral delivery system

Transfemoral access added into landmark APOLLO Pivotal Trial following IDE approval from FDA DUBLIN and ORLANDO, Fla., Nov. 6, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in...
Nov 5, 2021

Medtronic self-expanding TAVR platform shows excellent longer-term performance at five years in SURTAVI Trial

TCT 2021: Intermediate risk TAVR patients demonstrate strong hemodynamics and stable valve performance at five years DUBLIN and ORLANDO, Fla., Nov. 5, 2021 /PRNewswire/ -- Medtronic plc...
Nov 4, 2021

Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option

New data from Medtronic Patient Preference study presented at TCT 2021; Medtronic adds to its clinical leadership for renal denervation with launch of the SPYRAL AFFIRM study DUBLIN and ORLANDO,...
Oct 21, 2021

Austin L. Chiang, M.D., M.P.H. joins Medtronic as Chief Medical Officer for Gastrointestinal business

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced Austin L. Chiang, M.D., M.P.H., assistant professor of medicine at Sidney Kimmel Medical College, chief medical...
Oct 19, 2021

Children achieve Time in Range mirroring well-controlled adults for the first time in real-world study of the MiniMed™ 780G system

Harder to manage pediatric and adolescent patients achieve 74% Time in Range, and 82% overnight Time in Range, well surpassing clinical consensus guidelines for glycemic control DUBLIN, Oct. 19,...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa